Inhibition of CDK5 by ectopic expression of dominant-negative CDK5 constructs, or treatment of in vitro cultured cells with roscovitine significantly decreased the migration and invasion of pancreatic cancer cells [67]. This evidence concerns the gene CDK5 and pancreatic neoplasm.